Update Enrollment in the New Clozapine REMS Program

November 2015

Please see the FDA notice concerning Clozapine REMS program updates/deadline extensions.

A SINGLE new registry will streamline clozapine management.

We know clozapine is very effective for schizophrenia...but it's often a last resort due to neutropenia risk and its complex monitoring.

The new Clozapine REMS Program is now the ONLY registry available.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote